viimane versioon :
22/08/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Oseltamivir
keemiline struktuur
Viited : Oseltamivir
tüüp
avaldamine
2692
ajaleht
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
J Am Pharm Assoc 2007 ; 47, 6; 747-755.
3090
ajaleht
Voudrie MA, Brett Allen D.
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution).
Int J Pharm Compound 2010 ; 14, 1: 82-85.
3996
ajaleht
Dijkers E,Nanhekhan V,Thorissen A.
Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil.
Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177
ajaleht
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
Mentions Légales